ArticleBiologics : targets & therapy2022

Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet's Disease Complicated by Recurrent Enterocutaneous Fistulae.

Hitomi Kashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.